1029 related articles for article (PubMed ID: 25052475)
21. Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study.
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Eur J Heart Fail; 2011 Apr; 13(4):384-91. PubMed ID: 21239405
[TBL] [Abstract][Full Text] [Related]
22. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
Okin PM; Gerdts E; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B; Devereux RB;
Hypertension; 2008 Jul; 52(1):100-6. PubMed ID: 18504323
[TBL] [Abstract][Full Text] [Related]
23. Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.
Søraas CL; Wachtell K; Okin PM; Dahlöf B; Devereux RB; Tønnessen T; Kjeldsen SE; Olsen MH
Blood Press; 2010 Jun; 19(3):145-51. PubMed ID: 20429689
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
25. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
[TBL] [Abstract][Full Text] [Related]
26. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
[TBL] [Abstract][Full Text] [Related]
27. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B;
Ann Intern Med; 2007 Sep; 147(5):311-9. PubMed ID: 17785486
[TBL] [Abstract][Full Text] [Related]
28. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.
Okin PM; Kjeldsen SE; Julius S; Hille DA; Dahlöf B; Edelman JM; Devereux RB
Eur Heart J; 2010 Sep; 31(18):2271-9. PubMed ID: 20601389
[TBL] [Abstract][Full Text] [Related]
29. Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.
Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
Am J Hypertens; 2012 Oct; 25(10):1101-9. PubMed ID: 22717544
[TBL] [Abstract][Full Text] [Related]
30. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
[TBL] [Abstract][Full Text] [Related]
31. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
[TBL] [Abstract][Full Text] [Related]
32. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
[TBL] [Abstract][Full Text] [Related]
33. Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Devereux RB; Nieminen MS; Oikarinen L; Viitasalo M; Toivonen L; Ibsen H; Olsen MH; Borch-Johnsen K; Lindholm LH; Kjeldsen SE; Julius S; Dahlöf B;
Am J Hypertens; 2008 Mar; 21(3):273-9. PubMed ID: 18219298
[TBL] [Abstract][Full Text] [Related]
34. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
[TBL] [Abstract][Full Text] [Related]
35. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
Okin PM; Gerdts E; Wachtell K; Oikarinen L; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2010 Jul; 28(7):1534-40. PubMed ID: 20589977
[TBL] [Abstract][Full Text] [Related]
36. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
[TBL] [Abstract][Full Text] [Related]
39. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
[TBL] [Abstract][Full Text] [Related]
40. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
